Calcineurin Inhibitor–Free Immunosuppression Using Everolimus (Certican) in Maintenance Heart Transplant Recipients: 6 Months’ Follow-up-Reference-Cited by-同舟云学术

Calcineurin Inhibitor–Free Immunosuppression Using Everolimus (Certican) in Maintenance Heart Transplant Recipients: 6 Months’ Follow-up

Published:2007-03 Issue:3 Volume:26 Page:250-257
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

Rothenburger Markus,Teerling Elisa,Bruch Christian,Lehmkuhl Hans,Suwelack Barbara,Bara Christoph,Wichter Thomas,Hinder Frank,Schmid Christof,Stypmann Joerg

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference32 articles.

1. Calcineurin inhibitors in heart transplantation;Keogh;J Heart Lung Transplant,2004

2. Improving outcomes in heart transplantation: the potential of proliferation signal inhibitors;Eisen;Transplant Proc,2005

3. Organ Procurement and Transplantation Network reports 1996–2001. Available at http://www.optn.org.

4. Late acute cardiac allograft rejection: new therapeutic options?;Schweiger;Transplant Proc,2005

5. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs;Lindenfeld;Circulation,2004

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment with the calcineurin inhibitor and immunosuppressant cyclosporine A impairs sensorimotor gating in Dark Agouti rats;Psychopharmacology;2020-12-21

2. Oral health complications after a heart transplant: a review;British Dental Journal;2020-02

3. Blood Pressure in De Novo Heart Transplant Recipients Treated With Everolimus Compared With a Cyclosporine-based Regimen: Results From the Randomized SCHEDULE Trial;Transplantation;2019-04

4. The Challenges Associated With a Calcineurin Inhibitor-free Regimen After Heart Transplantation;Transplantation;2019-04

5. High-dose calcineurin inhibitor-free everolimus as a maintenance regimen for heart transplantation may be a risk factor for Pneumocystis pneumonia;Transplant Infectious Disease;2017-06-08